指南与共识肺结节与肺癌

AABIP循证指南:肺癌支气管镜诊断与分期

American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer
RSS 订阅 · 指南共识 · 肺结节与肺癌筛查 · 2025-09-30

美国支气管病与介入肺脏病学会(AABIP)组织多学科委员会,采用改良Delphi法确立9个PICO问题,系统检索截至2023年3月的文献,用GRADE评价证据质量并以NICE措辞表达推荐强度,最终提出9条推荐,其中6条有meta分析支持、3条有系统综述支持,涵盖外周肺结节支气管镜诊断与凸探头支气管内超声(CP-EBUS)纵隔分期。

要点

  • 指南提出9条推荐,6条基于meta分析、3条基于系统综述。
  • 内容涵盖外周支气管镜与经胸针吸活检的诊断率与并发症比较。
  • 涉及外周支气管镜多器械活检与快速现场评估(ROSE)的使用。

核心结论

  • 指南旨在标准化和简化肺癌支气管镜诊断与分期的推荐。
  • 因技术快速进步和观察性数据重要,需持续研究和证据更新以优化实践。
  • 建议临床医生根据当地条件、患者独特需求和新发现调整推荐。

研究设计与样本

  • AABIP召集多学科委员会制定循证与证据参考推荐。
  • 采用改良Delphi法创建并完善9个PICO问题。
  • 系统文献检索更新至2023年3月,作为起草推荐的基础。
  • 采用GRADE方法评价证据质量,并用NICE措辞表达推荐强度。
  • 适宜时完成meta分析,否则以系统综述和专家共识提供证据。

主要发现

  • 最终提出9条推荐:6条有meta分析支持,3条有系统综述支持。
  • 主题包括外周支气管镜与经胸针吸活检的诊断率与并发症率比较。
  • 主题包括外周支气管镜多活检器械使用与ROSE的作用。
  • 主题包括CP-EBUS引导纵隔分期的最佳实践。
  • 关键考量包括病灶大小、支气管镜新兴技术、可用资源与本地专长。

关键数值与推荐

  • 共9个PICO问题、9条推荐;6条基于meta分析,3条基于系统综述。
  • 系统文献检索更新至2023年3月。

临床怎么用

  • 临床可参照指南规范外周肺结节支气管镜诊断与CP-EBUS纵隔分期流程。
  • 开展外周支气管镜时应考虑多活检器械使用与ROSE的作用。
  • 实施推荐需结合本地资源、本地专长与患者个体情况。
  • 关注病灶大小和支气管镜技术进展对诊断策略的影响。

局限性

  • 部分推荐缺乏meta分析,仅依据系统综述和专家共识。
  • 领域技术快速进步与观察性数据占重要地位,需持续更新证据。
  • 原文未报告具体诊断率、并发症率等数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

J Bronchology Interv Pulmonol. 2025 Sep 30;32(4):e1034. doi: 10.1097/LBR.0000000000001034. eCollection 2025 Oct 1. ABSTRACT BACKGROUND: Lung cancer remains a predominant cause of cancer-related deaths worldwide, and there are notable geographic and institutional differences in both diagnostic and staging approaches. To address this, the American Association for Bronchology and Interventional Pulmonology (AABIP) convened a multidisciplinary committee to craft evidence-based and evidence-informed recommendations for diagnosing peripheral pulmonary nodules and performing convex probe endobronchial ultrasound (CP-EBUS)-guided mediastinal staging. METHODS: A modified Delphi method guided the creation and refinement of 9 Population, Intervention, Comparator, Outcome (PICO) questions. A systematic literature review, updated through March 2023, served as the basis for drafting recommendations. The panel used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to assess the quality of evidence and relied on National Institute for Health and Care Excellence (NICE) language to express the strength of each recommendation. Where suitable, meta-analyses were completed; otherwise, systematic reviews and consensus among experts provided the evidence for guidance. RESULTS: Nine recommendations were ultimately proposed: 6 were supported by meta-analyses and 3 by systematic reviews. The topics include comparing diagnostic yield and complication rates between peripheral bronchoscopy and transthoracic needle biopsy, the use of multiple biopsy instruments and the role of rapid on-site evaluation (ROSE) during peripheral bronchoscopy, and best practices for CP-EBUS-guided mediastinal staging. Several critical considerations emerged, such as lesion size, evolving technologies in bronchoscopy, and the importance of both available resources and local expertise. CONCLUSION: These guidelines aim to standardize and streamline recommendations for the bronchoscopic diagnosis and staging of lung cancer. Since rapid technological progress and observational data play significant roles in this field, ongoing research and evidence updates will be vital to refining best practices. Clinicians are advised to tailor these recommendations according to local circumstances, the unique needs of their patients, and any new findings as they develop. PMID: 41024606 | DOI: 10.1097/LBR.0000000000001034

来源:指南共识 · 肺结节与肺癌筛查,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 肺结节与肺癌筛查:American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。